Supported by the National Natural Science Foundation of China(NSFC)projects(No.81271606);the Research Fund of Science and Technology Department of Jilin Province(Nos.201015185 and 201201041);the Research Fund of Shenzhen Sci-tech Department of Guangdong Province(No.201102154)
In this paper,the safety and efficacy of 131I-labeled mouse/human chimeric monoclonal antibody(131I-chTNT)-mediated radioimmunotherapy are evaluated because the patients have non-uptaking 131I pulmonary metastases fro...
Supported by National Natural Science Foundation of China(NSFC)projects(No.81271606);Research Fund of Science and Technology Department of Jilin Province(No.201015185 and No.201201041);the Research Fund of Shenzhen Sci-tech Department of Guangdong Province(No.201102154)
In recent years,several RGD(Arg-Gly-Asp)-based radiotracers have already been successfully tested in human for the visualization of integrin αvβ3,demonstrating its feasibility in tumor diagnosis.In this paper,we eva...
Supported by the National Natural Science Foundation of China projects(No.81271606);the Research Fund of Science and Technology Department of Jilin province(No.200705327,No.201015185,and No.201201041);the Research Fund of Shenzhen Sci-tech Department of Guangdong province (No.201102154)
The 99mTc-3PRGD2 targeted SPECT/CT scanning was of significance in detecting differentiated glioma.In this work,the diagnostic value of 99mTc-3PRGD2 scintigraphy in brain glioma was evaluated by the ten clinically ver...
Supported by the National Natural Science Foundation of China(NSFC) projects(no.81271606);the Research Fund of Science and Technology Department of Jilin Province(no.201015185 and no.201201041);the Research Fund of Shenzhen Sci-tech Department of Guangdong Province(no.201102154)
99mTc-3PRGD2 is a new SPECT radiotracer for several tumor imaging with high uptake where integrinαvβ3 is highly expressed.This pilot study was to assess the safety,biodistribution and radiation dosimetry of 9,mTc-3P...